News Chinese buyers interested in J&J diabetes devices business Decision follows J&J's decision to close Animas insulin pump business
Views & Analysis Lilly collaborating with digital firm in 'real world' diabet... Rivals Novo Nordisk, Sanofi, and AstraZeneca also offering digital health services.
News Lilly to research real world diabetes with digital health fi... Eli Lilly and digital health firm Livongo are to collaborate on real-world studies and develop new insights into diabetes.
News Medicare to fund Abbott's needle-free diabetes monitor Abbott's new glucose monitoring device could be used by millions of diabetes patients in the US after government-funded health schemes agreed to pay for it.
News Merck/Pfizer undercut rivals with newly approved diabetes dr... Steglatro cheaper than SGLT2 rivals from AZ and Lilly/Boehringer
News Lilly partners with Rimidi on digital diabetes management to... Pharmaceutical companies in the diabetes market are all investing in tech to help doctors and patients manage the condition.
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
